Advanced search
Publication Cover
Gynecological Endocrinology Volume 36, 2020 - Issue 6
Submit an article Journal homepage
235
Views
1
CrossRef citations to date
0
Altmetric
CONTRACEPTION

Extended-cycle versus conventional treatment with a combined oral contraceptive containing ethinylestradiol (30 μg) and levonorgestrel (150 μg) in a randomized controlled trial

Peyman HadjiFrankfurter Hormon-und Osteoporosezentrum, Frankfurt am Main, Germany and Philipps-University of Marburg, Marburg, Germany; Correspondence[email protected]
View further author information
,
Joseph NeulenClinic for Gynaecological Endocrinology and Reproductive Medicine, University of Aachen, Aachen, Germany; View further author information
,
Katrin SchaudigCenter of Gynaecological Endocrinology, Hormone Hamburg, Hamburg, Germany; View further author information
,
Anneliese SchwenkhagenCenter of Gynaecological Endocrinology, Hormone Hamburg, Hamburg, Germany; View further author information
,
Stefanie GrimmbacherClinical Science and Operations, Meda Pharma GmbH and Co. KG (A Mylan Company), Bad Homburg, Germany; View further author information
&
Inka WiegratzVivaNeo Kinderwunschpraxis Frankfurt, Frankfurt am Main, GermanyView further author information
Pages 513-520 | Received 24 Jun 2019, Accepted 05 Jan 2020, Published online: 16 Feb 2020

References

  • Cibula D. Women´s contraceptive practices and sexual behaviour in Europe. Eur J Contracept Reprod Health Care. 2008;13(4):362–375.
  • Wiegratz I, Kuhl H. Langzyklus: Weniger menstruationen – Weniger menstruationsbeschwerden – weniger zyklusabhängige Erkrankungen. Stuttgart: Georg Thieme Verlag; 2010.
  • Andrist LC, Arias RD, Nucatola D, et al. Women’s and providers’ attitudes toward menstrual suppression with extended use of oral contraceptives. Contraception. 2004;70(5):359–363.
  • Wiegratz I, Kissler S, Kuhl H, et al. Extended and continuous use of hormonal contraceptives to reduce menstruation. Womens Health (Lond). 2006;2(5):705–716.
  • Fruzzetti F, Paoletti AM, Lombardo M, et al. Attitudes of Italian women concerning suppression of menstruation with oral contraceptives. Eur J Contracept Reprod Health Care. 2008;13(2):153–157.
  • Kuhl H, Birkhäuser M, Mueck A, et al. Long-cycle treatment in oral contraception. Ther Umsch. 2009;66(2):101–108.
  • den Tonkelaar I, Oddens BJ. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use. Contraception. 1999;59(6):357–362.
  • Wiegratz I, Kuhl H. Long-cycle treatment with oral contraceptives. Drugs. 2004;64(21):2447–2462.
  • Göretzlehner G. Menstrual bleeding – Must that be? Extended use of oral hormonal contraceptives. Zentralbl Gynakol. 2005;127(05):302–307.
  • Committee for medical products for human use (CHMP). Guideline on clinical investigation of steroid contraceptives in women (EMEA/CPMP/EWP/519/98 Rev 1); 2005. (cited 2018 Jun 13). Available from: www.ema.europa.eu/ema/pages/includes/document/open_document.jsp?webContentId=WC500003349.
  • Anderson FD, Hait H. A multicenter, randomised study of an extended-cycle oral contraceptive. Contraception. 2003;68(2):89–96.
  • Cremer M, Phan-Weston S, Jacobs A. Recent innovations in oral contraception. Semin Reprod Med. 2010;28(02):140–146.
  • Anderson FD, Gibbons W, Portman D. Long-term safety of an extended-cycle oral contraceptive (seasonale): a 2-year multicenter open-label extension trial. Am J Obstet Gynecol. 2006;195(1):92–96.
  • Anderson FD, Gibbons W, Portman D. Safety and efficacy of an extended-regimen oral contraceptive utilizing continuous low-dose ethinyl estradiol. Contraception. 2006;73(3):229–234.
  • Stephenson J, Shawe J, Panicker S, et al. Randomized trial of the effect of tailored versus standard use of the combined oral contraceptive pill on continuation rates at 1 year. Contraception. 2013;88(4):523–531.
  • ICH (International Council for Harmonisation). E6(R1) Good Clinical Practice (GCP) – step 5 version (EMA/CHMP/ICH/135/1995); July 2002 (cited 2018 Jun 13). Available from: http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html.
  • European Parliament. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Off J Eur Union. 2001. [cited 2018 Jun 13]. Available from: https://ec.europa.eu/health/human-use/clinical-trials/directive_en.
  • The Commission of the European Communities. Commission directive 2005/28/EC of 8 April 2005 laying down principles and detailed guidelines for good clinical practice as regards investigational medicinal products for human use, as well as the requirements for authorisation of the manufacturing or importation of such products. Off J Eur Union. 2005. [cited 2018 Jun 13]. Available from: https://ec.europa.eu/health/human-use/clinical-trials/information_en.
  • Preamble to the Constitution of WHO as adopted by the International Health Conference, New York, 19 June–22 July 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of WHO, no. 2, p. 100) and entered into force on 7 April 1948. The definition has not been amended since 1948; [cited 2018 Jun 13]. Available from: http://www.who.int/suggestions/faq/en/.
  • Belsey EM, Machin D, D´Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulation methods. World Health Organisation Special Programme of Research, Development and Research Training in Human Reproduction. Contraception. 1986; 34(3):253–260.
  • Gerlinger C, Endrikat E, van der Meulen EA, et al. Recommendation for confidence interval and sample size calculation for the Pearl Index. Eur J Contracept Reprod Health Care. 2003;8(2):87–92.
  • Wiegratz I, Hommel HH, Zimmermann T, et al. Attitude of German women and gynecologists towards long-cycle treatment with oral contraceptives. Contraception. 2004;69(1):37–42.
  • SPC Evaluna® 30, date of latest renewal: April 2017. www.fachinfo.de.
  • Mishell DR, Guillebaud J, Westhoff C, et al. Recommendation for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials. Contraception. 2007;75(1):11–15.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.